Offer - Urjas Oil for just ₹ 1
D Bose MP 375 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of D Bose MP 375 Tablet safe for pregnant women?
D Bose MP can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of D Bose MP 375 Tablet safe during breastfeeding?
Taking D Bose MP may lead to serious side effects if you are breastfeeding. D Bose MP should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of D Bose MP 375 Tablet on the Kidneys?
D Bose MP may have mild side effects on the kidneys.
What is the effect of D Bose MP 375 Tablet on the Liver?
Effects of D Bose MP on the liver can be severe. It is not safe for use without doctor's advice.
What is the effect of D Bose MP 375 Tablet on the Heart?
D Bose MP has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take D Bose MP 375 Tablet unless your doctor advises you to do so -
Is this D Bose MP 375 Tablet habit forming or addictive?
No, there is no any evidence that D Bose MP 375 Tablet is addictive.
Interaction between Food and D Bose MP 375 Tablet
Due to a lack of research, nothing can be said about the consequences of taking D Bose MP 375 Tablet together with food.
Interaction between Alcohol and D Bose MP 375 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking D Bose MP 375 Tablet.
D Bose MP helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, D Bose MP is not approved for weight loss, this is an off-label use.
D Bose MP should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
D Bose MP is not a known cause of alopecia (hair loss). However, the conditions treated by D Bose MP type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Lactic acidosis associated with D Bose MP treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of D Bose MP induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277